Mediwhale
Latest round
- Series C
Last raised
- Mar 2026
Total raised
- $24M
Investors
- 15
About Mediwhale
Established in 2016 and based in Seoul, South Korea, Mediwhale Inc. uses artificial intelligence technology to find cardiovascular risk by using retinal images as biomarkers. The company develops an AI that enables the diagnosis of heart disease based on fundus image analysis. In March 2026, Mediwhale Inc. The company operates DrNoon for CVD, an artificial intelligence-based medical device that can evaluate cardiovascular risk through an eye examination. MediWhale Inc. also uses IVUS, a catheter with ultrasound equipment used to observe a patient’s coronary artery. MediWhale Inc. plans to accelerate its entry into the domestic and overseas medical markets of DrNoon for CVD and retina-based cardiovascular risk assessment AI.
Who invested in Mediwhale
15 investors across 4 rounds
See all investors in Mediwhale
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mediwhale
Who invested in Mediwhale?
Mediwhale has 15 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mediwhale raised?
Mediwhale has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Mediwhale last raise money?
Mediwhale's most recent round on record is a Series C, in Mar 2026.
What does Mediwhale do?
Established in 2016 and based in Seoul, South Korea, Mediwhale Inc.
Where is Mediwhale headquartered?
Mediwhale is headquartered in Seoul, South Korea.
Which VCs invest in companies like Mediwhale?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, Taibao Capital and Hengxu Capital back healthcare companies at Mediwhale's stage. Their profiles are linked below.
VCs backing healthcare startups at Series C
Raising like Mediwhale? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.